2Chang LC,Haggstrom AN,Drolet BA,et al.Growth characteristics of infantile hemangiomas:Implications for management[J] .Pediatrics,2008,122(2):360-367.
3Léauté-Labrèze C,Dumas de la Roque E,Hubiche T,et al.Propranolol for severe hemangiomas of infancy[J] .N Engl J Med,2008,358(24):2649-2651.
4Drolet BA,Swanson EA,Frieden IJ,et al.Infantile hemangiomas:An emerging health issue linked to an increased rate of low birth weight infants[J] .J Pediatr,2008,153(5):712-715.
5Mulliken JB,Glowacki J.Hemangiomas and vascular malformations in infants and children:A classification based on endothelial characteristics[J] .Plast Reconstr Surg,1982,69(3):412-422.
6Powell J.Update on hemangiomas and vascular malformations[J] .Cur Opin Pediatr,1999,11(5):457-463.
7Zvulunov A,Metzker A.Hemangiomas and vascular malformations:Unapproved treatments[J] .Clin Dermatol,2002,20(6):660-667.
8Frieden IJ,Eichenfield LF,Esterly NB,et al.Guidelines of care for hemangiomas of infancy.American Academy of Dermatology Guidelines/Outcomes Committee[J] .J Am Acad Dermatol,1997,37(4):631-637.
10Sanchez CI,Mihm MC,Waner M.Laser and intense pulsed light in the treatment of infantile haemangiomas and vascular malformations[J] .An Sist Sanit Navar,2004,27(suppl1):103-115.
